Skip to main content
. 1998 Jan;36(1):123–127. doi: 10.1128/jcm.36.1.123-127.1998

TABLE 2.

Comparison of CME and Peptilav testing for the type-specific serodiagnosis of HIV-1, HIV-2, and HIV-D in the prospective evaluation

CME serodiagnosis No. with Peptilav serodiagnosisa
HIV-1 HIV-2 HIV-D Total
HIV-1 106 0 47 153
HIV-2 0 40 4 44
HIV-D 0 1 69 70
 Total 106 41 120 267
a

Sera collected consecutively were tested by Peptilav and the CME strategy.